These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16149099)

  • 21. [Malignant neuroleptic syndrome].
    Courtine JC; Blot P
    Nouv Presse Med; 1981 May; 10(21):1749. PubMed ID: 6112732
    [No Abstract]   [Full Text] [Related]  

  • 22. An unrecognised case of withdrawal neuroleptic malignant syndrome: a case report.
    Ball H; de Waal H; Craig K
    Med Sci Law; 2009 Oct; 49(4):298-300. PubMed ID: 20025106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ; Callaghan WD
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug treatment of hyperkinetic movement disorders.
    Howsepian AA
    Semin Neurol; 1987 Dec; 7(4):382. PubMed ID: 2902676
    [No Abstract]   [Full Text] [Related]  

  • 26. 'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality.
    Gillman PK
    Med Sci Law; 2011 Apr; 51(2):122-3; author reply 124. PubMed ID: 21793478
    [No Abstract]   [Full Text] [Related]  

  • 27. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The parkinsonism-hyperpyrexia syndrome.
    Newman EJ; Grosset DG; Kennedy PG
    Neurocrit Care; 2009; 10(1):136-40. PubMed ID: 18712508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.
    Kornhuber J; Weller M; Riederer P
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):63-72. PubMed ID: 8105799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant syndromes: current advances.
    Tao M; Li J; Wang X; Tian X
    Expert Opin Drug Saf; 2021 Sep; 20(9):1075-1085. PubMed ID: 33866917
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.
    Tollefson G
    J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperthermic syndromes.
    Danzl DF
    Am Fam Physician; 1988 Jun; 37(6):157-62. PubMed ID: 3289339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypophosphatemia and neuroleptic malignant syndrome.
    Seitz DP
    J Clin Psychopharmacol; 2007 Jun; 27(3):302-3. PubMed ID: 17502779
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute dopamine deficiency and malignant neuroleptic-like syndrome].
    Ezrielev GZ
    Harefuah; 1992 Apr; 122(8):503-5, 551. PubMed ID: 1398317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome associated with quetiapine.
    al-Waneen R
    Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
    [No Abstract]   [Full Text] [Related]  

  • 37. Movement disorder emergencies.
    Kipps CM; Fung VS; Grattan-Smith P; de Moore GM; Morris JG
    Mov Disord; 2005 Mar; 20(3):322-34. PubMed ID: 15584031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 39. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Malignant hyperpyrexia caused by neuroleptics].
    Escolano Villén F; López Bosque R
    Rev Esp Anestesiol Reanim; 1988; 35(4):214-7. PubMed ID: 3051179
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.